Ashkan Shoamanesh: Should Intracranial Hemorrhage Survivors with AFib Receive Anticoagulation?
Ashkan Shoamanesh, Associate Professor of Medicine (Neurology), Marta and Owen Boris Chair in Stroke Research and Care at McMaster University, shared on LinkedIn:
”Should intracranial hemorrhage (ICrH) survivors with atrial fibrillation receive anticoagulation?
If so: under which clinical circumstances?, after what time interval?, with what strategies to mitigate ICrH recurrence risk? and what is the level of supporting evidence?
These are common yet challenging questions in stroke practice, with many remaining unresolved.
We address them in detail in our recently published comprehensive review in the European Stroke Organisation Journal.”
Read the full article here.
Article: Oral Anticoagulation following intracranial haemorrhage in patients with atrial fibrillation
Authors: Ashkan Shoamanesh, Catharina JM Klijn, Kevin N Sheth, Roland Veltkamp, Else C Sandset, Charlotte Cordonnier, Rustam Al-Shahi Salman
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 9, 2026, 12:17Louise St Germain Bannon Invites You to Self-Nominate for the ISTH Council
-
Jan 9, 2026, 09:25Emma Groarke Shares A Comprehensive Review on VEXAS Syndrome
-
Jan 9, 2026, 09:13Anirban Sen Gupta Presents PlateChek
-
Jan 9, 2026, 08:58Oscar Pena Shares KDIGO 2026 Update: 5 Critical Changes for Anemia in CKD Management
-
Jan 9, 2026, 07:38Bartosz Hudzik on Subacute Coronary Occlusions: Navigating the Gray Zone in CAD Care
-
Jan 9, 2026, 07:27Gregory Piazza on The Role of D-Dimer in VTE Evaluation
-
Jan 9, 2026, 07:19Emmanuel J Favaloro Shares the 1st Article in a VWD Series Marking the 100-Year Anniversary
-
Jan 9, 2026, 07:07Taylor Robichaux on Recombinant ADAMTS13 Therapy in cTTP
-
Jan 9, 2026, 06:25Sara Ng: VTE Continues to Plague Modern Oncology